Restore Mind Medicine

Our History of Engagement September 2022 MindMed proposed one mutually agreeable director at the next AGM. After FCM rejected this proposal, MindMed embarked on a value destructive, dilutive offering that diluted FCM's stake in the Company and impeded its ability to requisition a meeting. April 2023 FCM sent a letter to the Board to try to find a path forward which would avoid a proxy campaign. May 2023 After MindMed presented the same proposal as before, FCM nominated four exceptional candidates for the Board and filed its definitive proxy materials. 10

View entire presentation